Ivachtin is primarily recognized for its role in the research and development of treatments for various diseases, particularly those involving protein misfolding and aggregation. It has been studied for its potential to inhibit the aggregation of amyloid-beta peptides, which are implicated in the pathogenesis of Alzheimer's disease. By preventing the formation of toxic amyloid plaques, Ivachtin offers a promising avenue for therapeutic intervention in neurodegenerative disorders. Additionally, its application extends to the study of other protein misfolding diseases, such as Parkinson's and Huntington's, where it helps researchers understand the mechanisms of protein aggregation and identify potential drug targets. Beyond neurodegenerative research, Ivachtin has also been explored in cancer studies, where it may influence cellular pathways involved in tumor growth and survival. Its versatility in modulating biological processes makes it a valuable tool in both basic science and drug discovery efforts.